On 26 April 2023, the "2022 China Healthcare Industry Investment and Financing Honor List" was officially announced. Trinity Innovation Fund and the portfolio companies won multiple awards.

The 2022 China Healthcare Industry Investment and Financing Honor List was jointly sponsored by CHC (China Healthcare Consulting) and CITIC Securities. It is based on the review of the current state of development of investment and financing in the medical and health industry, and a combination of criteria such as institutional activity, number of investment projects, excellent cases, investment returns, total assets under management, portfolio companies’ financing and development and, valuation. The selected institutions within the honor list are selected based on the principle of fairness and impartiality.

TIF won the following awards in the 2022 Honor List:

-   TOP 20 Investment Institutions with the Most Growth Potential in Healthcare

-   TOP 50 Most Influential Investors of the Year

Our portfolio companies also gained awards in the industry sub-list:

-   Thousand Oaks Biopharmaceuticals, Top 50 Most Influential Companies in Healthcare of the Year

-   Bluepha Co., Ltd., Top 50 Most Valuable Investment Companies in Healthcare of the Year

TIBS will continue to help passionate scientists and entrepreneurs develop ground-breaking scientific research into successful corporate ventures. Partnering with scientists and entrepreneurs, TIBS aims to transform innovations into cures for humanity. With profound industry knowledge and substantial resources, we are committed to accelerating the growth of its portfolio companies via strategy optimization, recruitment of key positions, collaborative partnerships and much more.

To view the complete list, please click: List Announced! " 2022 China Healthcare Industry Investment and Financing Honor List"